Bio/Pharma News

Nov 11, 2013
Former President Jimmy Carter and Pfizer mark milestone for long-standing partnership to combat trachoma in the developing world.
Nov 11, 2013
By Pharmaceutical Technology Editors
Shire-s agreement to acquire ViroPharma will strengthen its rare-disease portfolio.
Nov 06, 2013
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
Nov 06, 2013
By Pharmaceutical Technology Editors
ISPE names Novartis' US Flu Cell Culture facility as award winner.
Nov 04, 2013
By Pharmaceutical Technology Editors
Allegations include off-label marketing for Risperdal, Invega and Natrecor and kickbacks to doctors and pharmacists.
Oct 29, 2013
By Pharmaceutical Technology Editors
GSK and the Gates Foundation will invest a combined $1.8 million in early stage research into vaccine thermostability.
Oct 28, 2013
By Pharmaceutical Technology Editors
Zhoydro ER is the first drug to have updated labeling now required for all ER/LA opioid analgesics.
Oct 23, 2013
By Pharmaceutical Technology Editors
Amarin cuts staff in half after an FDA committee rejects its product label expansion.
Oct 23, 2013
By Pharmaceutical Technology Editors
Big pharma companies Novartis, Amgen, and Bristol-Myers Squibb announce positive third-quarter 2013 results.
Oct 22, 2013
By Pharmaceutical Technology Editors
FDA has awarded 15 grants totaling more than $14 million to boost the development of products for patients with rare diseases.
native1_300x100
lorem ipsum